Alnylam Pharmaceuticals
ALNY
#637
Rank
โ‚ฌ34.22 B
Marketcap
256,31ย โ‚ฌ
Share price
-1.02%
Change (1 day)
0.53%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company